Holen Sie sich die Stockscreener-App
180.06
0.50%
0.89
Handel nachbörslich:
180.06
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$179.17
Offen:
$179
24-Stunden-Volumen:
506.45K
Relative Volume:
0.58
Marktkapitalisierung:
$11.49B
Einnahmen:
$13.84B
Nettoeinkommen (Verlust:
$1.10B
KGV:
17.28
EPS:
10.4185
Netto-Cashflow:
$1.49B
1W Leistung:
-2.02%
1M Leistung:
-22.52%
6M Leistung:
+20.89%
1J Leistung:
+33.98%
1-Tages-Spanne:
$178.92
$182.69
1-Wochen-Bereich:
$176.85
$186.96
52-Wochen-Spanne:
$101.00
$247.49
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
180.06 | 11.58B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
404.68 | 89.76B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
267.90 | 21.48B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.77 | 12.62B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
123.59 | 12.31B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
DaVita Inc. (DVA) Stock forecasts - Yahoo Finance UK
The Top 5 Analyst Questions From DaVita’s Q2 Earnings Call - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Community Care Report 2025: Creating a Culture of Belonging for All - CSRwire
DaVita Inc. $DVA Shares Sold by Wedge Capital Management L L P NC - MarketBeat
Pacer Advisors Inc. Trims Position in DaVita Inc. $DVA - MarketBeat
DaVita Inc. $DVA Shares Sold by Empowered Funds LLC - MarketBeat
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Are Wall Street Analysts Bullish on DaVita Stock? - Yahoo Finance
DaVita Inc. $DVA Shares Acquired by Assenagon Asset Management S.A. - MarketBeat
DaVita Inc. (DVA) Stock Analysis: Strong Upside Potential with an 18.86% Gain on the Horizon - DirectorsTalk Interviews
9,300 Shares in DaVita Inc. $DVA Purchased by Polianta Ltd - MarketBeat
DaVita (DVA) Stock Still Looks Undervalued Despite A Q2 Earnings Beat - Yahoo Finance
DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada
Can DaVita’s (DVA) Better Mortality Trends Redefine Its Core Dialysis Investment Story? - webull.com
Why is DaVita stock up 2% today? - Investing.com
DaVita Inc (DVA) Stock News Today - TradingKey
TD Cowen upgrades DaVita stock rating on market position gains - Investing.com
DaVita Shares Rise After TD Cowen Upgrades Stock to Buy - Yahoo Finance
Janus Henderson Group PLC Raises Stock Position in DaVita Inc. $DVA - MarketBeat
DaVita Inc (DVA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is DaVita (DVA) a Great Value Stock Right Now? - Yahoo Finance
DaVita Inc. $DVA Shares Bought by California State Teachers Retirement System - MarketBeat
DaVita Inc. (DVA) options chain - Yahoo Finance Australia
SPDR S&P 500(R) Buyback ETF's DaVita Inc(DVA) Holding History - GuruFocus
DaVita Inc (DVA) Shares Fall 17.2% -- GF Value Says Still Overva - GuruFocus
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita Stock Down in Pre-Market Despite Q2 Earnings Beat, Margins Down - Yahoo Finance
DVA Q2 Deep Dive: Flat Volumes and Policy Transitions Shape Outlook - StockStory
DVA Q2 Earnings Call Centers on Clinical-Led Volume Growth - The Globe and Mail
DaVita Inc. $DVA Shares Sold by Amundi - MarketBeat
DaVita Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
DaVita Inc. Stock 12‑Month Price Target Raised to $230, Implies 1% Upside - TradingView
Is DaVita Inc (DVA) Overvalued After Q2 Earnings Beat? EPS at $4 - GuruFocus
DaVita Expands Access to Advanced Middle Molecule Clearance - DaVita Newsroom
DaVita Q2 Earnings Call Highlights - TradingView
DaVita Inc (DVA) (Q2 2026) Earnings Call Highlights: Strong Volu - GuruFocus
DaVita's Profit Growth Prospects Boosted by Share Repurchases - Morningstar
Earnings call transcript: DaVita beats Q2 2026 estimates but shares fall - Investing.com
DaVita Inc reports results for the quarter ended June 30Earnings Summary - TradingView
DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
DaVita Slides as Solid Q2 Results Fail to Lift Full-Year Outlook - Quiver Quantitative
DaVita (NYSE:DVA) Beats Q2 CY2026 Sales Expectations But Stock Drops - StockStory
DaVita Inc. 2026: Revenue $3.55B, EPS $4.02— 10-Q Summary - TradingView
[10-Q] DAVITA INC. Quarterly Earnings Report - Stock Titan
Q2 2026 DaVita Inc Earnings Call Transcript - GuruFocus
Earnings Flash (DVA) DaVita Inc. Posts Q2 Adjusted EPS $4.02 per Share, vs. FactSet Est of $3.88 - marketscreener.com
DaVita reports Q2 2026: Revenue $3.554B, Operating income $579M, Diluted EPS $4.02 - TradingView
DaVita (NYSE: DVA) Q2 earnings show $3.55B revenue and strong cash flow - stocktitan.net
DaVita Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Davita Inc-Aktie (DVA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Waters Kathleen Alyce | Chief Legal & Pub. Affairs Off |
Jun 15 '26 |
Sale |
208.40 |
15,405 |
3,210,377 |
109,194 |
| Rodriguez Javier | Chief Executive Officer |
Jun 16 '26 |
Sale |
209.28 |
39,407 |
8,247,018 |
840,408 |
| Rodriguez Javier | Chief Executive Officer |
Jun 15 '26 |
Sale |
209.50 |
30,000 |
6,285,090 |
879,815 |
0.03%
0.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):